AKT1 and B-cell chronic lymphocytic leukemia: This model of CLL is indeed relevant also to assess the protective role of the stromal microenvironment for CLL cells upon treatment, since the tcl-1 gene, encoding an AKT co-activator, is significantly upregulated in CLL B lymphocytes upon co-culturing with stromal cells [74].